The week in health tech, explained in plain English.Get the free newsletter →
November 8, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Government

CMS Ends Medicaid, CHIP Funding for Youth Gender Care

CMS has finalized a rule that prevents federal Medicaid and Children's Health Insurance Program dollars from funding gender-affirming care for minors. According to Becker's Hospital Review, which reviewed the rule Aug. 11, the change takes effect Oct. 13.

In practice, the rule blocks states from tapping federal matching funds for puberty blockers, gender-affirming hormone therapy, and related surgeries such as mastectomies for patients under a certain age. Federal money typically covers a large share of state Medicaid spending, so removing that match forces a decision at the state level: absorb the full cost using state-only funds or stop covering the services altogether.

The move fits a broader federal push to restrict pediatric gender care and will likely deepen the divide between states. Hospitals, pediatric providers, and Medicaid managed-care plans will need to review coverage policies, patient communications, and billing ahead of the October deadline, especially in states that have supported this care.

More in Government

Government

BIO Sues to Block Medicare Peer-Country Drug Pricing Pilot

BIO has sued to block a Medicare pilot that ties certain US drug prices to peer-country benchmarks, the latest challenge to Trump's most-favored-nation pricing push.

Why it matters: The outcome will shape how far the federal government can use Medicare pilots to push US drug prices toward what other countries pay.

Government

CMS Finalizes 2.4% Home Health Pay Bump for 2027

CMS finalized a 2.4% home health payment increase for 2027 while tightening Medicare provider enrollment rules to fight fraud.

Why it matters: The rule sets 2027 reimbursement for home health agencies and raises compliance stakes as CMS cracks down on fraud.

Government

CMS Makes Medicare Drug Price Negotiation Rules Permanent

CMS finalized a rule making its Medicare Drug Price Negotiation Program framework permanent, setting lasting policies for negotiated prices starting in 2029.

Why it matters: A permanent framework gives drugmakers, payers, and providers a stable rulebook to plan pricing and contracting around instead of chasing year-by-year changes.